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The gene expression programs regulated by the Myc transcription
factor were evaluated by integrated genome-wide proﬁling of Myc
binding sites, chromatin marks and RNA expression in several
biological models. Our results indicate that Myc directly drives
selective transcriptional regulation, which in certain physiological
conditions may indirectly lead to RNA ampliﬁcation. Here, we
illustrate in detail the experimental design concerning the high-
throughput sequencing data associated with our study (Sabò et al.,
Nature. (2014) 511:488–492) and the R scripts used for their
computational analysis.
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line/tissueHuman (P493-6 B cells), mouse (Eμ-myc B cells, 3T9 ﬁbroblasts)Sex Not applicable
Sequencer or array
typeIllumina Hi-Seq 2000Data format Raw and analyzed
Experimental
factorsEl-myc: wild type B-cells (Control, “C”), Em-myc transgenic B-cells not yet transformed (Pre-tumoral, “P”),
and lymphoma cells (Tumor, “T”)
3T9.Serum: 3T9 ﬁbroblasts serum starved (t0 h) or released for 1 (t1 h) or 2 (t2 h) hours
3T9.mycER: MycER-infected 3T9 ﬁbroblasts untreated (0 hOHT) or treated for different periods of times
with OHT (4, 8, 16 hOHT) to activate the MycER chimera.
P493: P493-6 cells treated with Tetracycline (Myc transgene repressed) for 72 h (t0) and then released in
fresh medium without Tetracycline (allowing expression of the transgene) for 1 h (t1 h), 24 h (t24 h) or
several passages (“High Myc”). P493-6 cells treated with Tetracycline (Myc transgene repressed) plus OHT
(endogenous Myc activated: “Low Myc”)Experimental
featuresCells with the indicated genotype/treatment were used for ChIP-Seq (for Myc, RNAPII, H3K4me3, H3K4me1,
H3K27ac), totRNA-Seq, 4sU-RNA-Seq or DNAse-Seq experiments, as reportedConsent n/a
Sample source
locationMilan, Italy1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51011.2. Experimental design
The Gene Expression Omnibus (GEO) Series GSE51011 contains 94 high-throughput sequencing
samples associated with the Sabò et al. study [1]. These samples cover different –omics datasets (ChIP-
Seq for transcription factors and post-translational histone modiﬁcations, RNA-Seq, 4sU-Seq and
DNAseI-Seq) produced in different organisms and biological systems. Some of the samples have to be
used as references for other samples: for example, as inputs in the ChIP-seq peak calling procedure, or
as baselines for the identiﬁcation of differentially expressed genes. To help navigating through these
data we collected the most relevant associated metadata in Table 1.
The different biological systems used in the study allowed the analysis of the effects of modulation
of Myc levels in vitro and in vivo, both at physiological and pathological levels. In the Eμ-myc model
[2], Myc overexpression was achieved in vivo speciﬁcally in the mouse B-cell compartment, where
it causes lymphoma development. This model system gave access to primary wild type B-cells
(Control, “C”), Em-myc transgenic B-cells not yet transformed (Pre-tumoral, “P”), and lymphoma
tumoral cells (Tumor, “T”). Modulation of Myc expression in human B-cells was obtained in a time-
controlled manner in vitro in the cell line P493-6 [3], harboring a tet-regulated Myc transgene. A line
of mouse 3T9 ﬁbroblasts was also used in which endogenous c-myc was modulated from low basal
levels (in conditions of serum starvation) to mitogen-induced levels (upon serum stimulation). In the
same cells, we expressed a conditionally active MycER chimaera, allowing us to induce active Myc at
supra-physiological levels through administration of OHT to the culture medium.3. Data analysis: Source code design and installation
In addition to the methods in the original publication [1], the source code used for the computational
analysis of the high-throughput sequencing data is available as supplemental material of this manuscript.
Table 1
Key features of the 94 samples available in the GSE51011 series (rep¼replicate, org¼organism, mmu¼mm9, hsa¼hg18).
Sample id Sample name Rep Data type Target Org Biological model Input/baseline
GSM1234471 Eu-myc.Myc.C.1 1/1 ChIP-Seq Myc mmu Eμ-myc GSM1395178
GSM1395178 Eu-myc.input.C1 1/1 ChIP-Seq Myc mmu Eμ-myc –
GSM1234472 Eu-myc.Myc.P.1 1/3 ChIP-Seq Myc mmu Eμ-myc GSM1395179
GSM1395179 Eu-myc.input.P1 1/1 ChIP-Seq Myc mmu Eμ-myc –
GSM1234473 Eu-myc.Myc.P.2 2/3 ChIP-Seq Myc mmu Eμ-myc GSM1234498
GSM1234474 Eu-myc.Myc.P.3 3/3 ChIP-Seq Myc mmu Eμ-myc GSM1234498
GSM1234475 Eu-myc.Myc.T.1 1/1 ChIP-Seq Myc mmu Eμ-myc GSM1234498
GSM1234476 Eu-myc.Myc.T.2 1/1 ChIP-Seq Myc mmu Eμ-myc GSM1234498
GSM1234477 Eu-myc.Myc.T.3 1/1 ChIP-Seq Myc mmu Eμ-myc GSM1234498
GSM1234478 Eu-myc.Pol2.C.1 1/1 ChIP-Seq Pol2 mmu Eμ-myc GSM1234498
GSM1234479 Eu-myc.Pol2.P.1 1/1 ChIP-Seq Pol2 mmu Eμ-myc GSM1234498
GSM1234480 Eu-myc.Pol2.T.1 1/1 ChIP-Seq Pol2 mmu Eμ-myc GSM1234498
GSM1234481 Eu-myc.Pol2.T.2 1/1 ChIP-Seq Pol2 mmu Eμ-myc GSM1234498
GSM1234482 Eu-myc.Pol2.T.3 1/1 ChIP-Seq Pol2 mmu Eμ-myc GSM1234498
GSM1234483 Eu-myc.H3K4me3.C1 1/2 ChIP-Seq H3K4me3 mmu Eμ-myc GSM1234498
GSM1234517 Eu-myc.H3K4me3.C2 2/2 ChIP-Seq H3K4me3 mmu Eμ-myc GSM1234498
GSM1234484 Eu-myc.H3K4me3.P1 1/2 ChIP-Seq H3K4me3 mmu Eμ-myc GSM1234498
GSM1234518 Eu-myc.H3K4me3.P2 2/2 ChIP-Seq H3K4me3 mmu Eμ-myc GSM1234498
GSM1234485 Eu-myc.H3K4me3.T1 1/1 ChIP-Seq H3K4me3 mmu Eμ-myc GSM1234498
GSM1234486 Eu-myc.H3K4me3.T2 1/1 ChIP-Seq H3K4me3 mmu Eμ-myc GSM1234498
GSM1234487 Eu-myc.H3K4me3.T3 1/1 ChIP-Seq H3K4me3 mmu Eμ-myc GSM1234498
GSM1234488 Eu-myc.H3K4me1.C1 1/2 ChIP-Seq H3K4me1 mmu Eμ-myc GSM1234498
GSM1234519 Eu-myc.H3K4me1.C2 2/2 ChIP-Seq H3K4me1 mmu Eμ-myc GSM1234498
GSM1234489 Eu-myc.H3K4me1.P1 1/2 ChIP-Seq H3K4me1 mmu Eμ-myc GSM1234498
GSM1234520 Eu-myc.H3K4me1.P2 2/2 ChIP-Seq H3K4me1 mmu Eμ-myc GSM1234498
GSM1234490 Eu-myc.H3K4me1.T1 1/1 ChIP-Seq H3K4me1 mmu Eμ-myc GSM1234498
GSM1234491 Eu-myc.H3K4me1.T2 1/1 ChIP-Seq H3K4me1 mmu Eμ-myc GSM1234498
GSM1234492 Eu-myc.H3K4me1.T3 1/1 ChIP-Seq H3K4me1 mmu Eμ-myc GSM1234498
GSM1234493 Eu-myc.H3K27ac.C 1/1 ChIP-Seq H3K27ac mmu Eμ-myc GSM1234498
GSM1234494 Eu-myc.H3K27ac.P 1/1 ChIP-Seq H3K27ac mmu Eμ-myc GSM1234498
GSM1234495 Eu-myc.H3K27ac.T1 1/1 ChIP-Seq H3K27ac mmu Eμ-myc GSM1234498
GSM1234496 Eu-myc.H3K27ac.T2 1/1 ChIP-Seq H3K27ac mmu Eμ-myc GSM1234498
GSM1234497 Eu-myc.H3K27ac.T3 1/1 ChIP-Seq H3K27ac mmu Eμ-myc GSM1234498
GSM1234498 Eu-myc.input.CPT 1/1 ChIP-Seq – mmu Eμ-myc –
GSM1386348 3T9.Serum.Myc.t0h 1/1 ChIP-Seq Myc mmu 3T9.Serum GSM1386351
GSM1386349 3T9.Serum.Myc.t1h 1/1 ChIP-Seq Myc mmu 3T9.Serum GSM1386351
GSM1386350 3T9.Serum.Myc.t2h 1/1 ChIP-Seq Myc mmu 3T9.Serum GSM1386351
GSM1386351 3T9.Serum.input 1/1 ChIP-Seq – mmu 3T9.Serum –
GSM1234500 P493.Myc.LowMyc 1/1 ChIP-Seq Myc hsa P493 GSM1386347
GSM1234501 P493.Myc.HighMyc 1/1 ChIP-Seq Myc hsa P493 GSM1386347
GSM1234499 P493.Myc.t0h 1/1 ChIP-Seq Myc hsa P493 GSM1386347
GSM1386342 P493.Myc.t1h 1/1 ChIP-Seq Myc hsa P493 GSM1386347
GSM1386343 P493.Myc.t24h 1/1 ChIP-Seq Myc hsa P493 GSM1386347
GSM1234502 P493.Pol2.t0h 1/1 ChIP-Seq Pol2 hsa P493 GSM1386347
GSM1386344 P493.Pol2.t24h 1/1 ChIP-Seq Pol2 hsa P493 GSM1386347
GSM1386345 P493.H3K4me3.t24h 1/1 ChIP-Seq H3K4me3 hsa P493 GSM1386347
GSM1386346 P493.H3K27ac.t24h 1/1 ChIP-Seq H3K27ac hsa P493 GSM1386347
GSM1386347 P493.input 1/1 ChIP-Seq – hsa P493 –
GSM1234505 3T9.mycER.Pol2.0hOHT 1/1 ChIP-Seq Pol2 mmu 3T9.mycER GSM1234507
GSM1234506 3T9.mycER.Pol2.4hOHT 1/1 ChIP-Seq Pol2 mmu 3T9.mycER GSM1234507
GSM1234507 3T9.mycER.input.Pol2 1/1 ChIP-Seq - mmu 3T9.mycER -
GSM1234508 3T9.mycER.Myc.0hOHT 1/1 ChIP-Seq Myc mmu 3T9.mycER GSM1234516
GSM1234509 3T9.mycER.Myc.4hOHT 1/1 ChIP-Seq Myc mmu 3T9.mycER GSM1234516
GSM1234510 3T9.mycER.H3K4me3.0hOHT 1/1 ChIP-Seq H3K4me3 mmu 3T9.mycER GSM1234516
GSM1234511 3T9.mycER.H3K4me3.4hOHT 1/1 ChIP-Seq H3K4me3 mmu 3T9.mycER GSM1234516
GSM1234512 3T9.mycER.H3K4me1.0hOHT 1/1 ChIP-Seq H3K4me1 mmu 3T9.mycER GSM1234516
GSM1234513 3T9.mycER.H3K4me1.4hOHT 1/1 ChIP-Seq H3K4me1 mmu 3T9.mycER GSM1234516
GSM1234514 3T9.mycER.H3K27ac.0hOHT 1/1 ChIP-Seq H3K27ac mmu 3T9.mycER GSM1234516
GSM1234515 3T9.mycER.H3K27ac.4hOHT 1/1 ChIP-Seq H3K27ac mmu 3T9.mycER GSM1234516
GSM1234516 3T9.mycER.input.OHT 1/1 ChIP-Seq – mmu 3T9.mycER –
GSM1234734 Eu-myc.RNAseq.C_1 1/4 RNA-Seq totRNA mmu Eμ-myc –
GSM1234735 Eu-myc.RNAseq.C_3 2/4 RNA-Seq totRNA mmu Eμ-myc –
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Table 1 (continued )
Sample id Sample name Rep Data type Target Org Biological model Input/baseline
GSM1234736 Eu-myc.RNAseq.C_4 3/4 RNA-Seq totRNA mmu Eμ-myc –
GSM1234737 Eu-myc.RNAseq.C_6 4/4 RNA-Seq totRNA mmu Eμ-myc –
GSM1234738 Eu-myc.RNAseq.P_2 1/4 RNA-Seq totRNA mmu Eμ-myc GSM1234734-7
GSM1234739 Eu-myc.RNAseq.P_3 2/4 RNA-Seq totRNA mmu Eμ-myc GSM1234734-7
GSM1234740 Eu-myc.RNAseq.P_4 3/4 RNA-Seq totRNA mmu Eμ-myc GSM1234734-7
GSM1234741 Eu-myc.RNAseq.P_5 4/4 RNA-Seq totRNA mmu Eμ-myc GSM1234734-7
GSM1234742 Eu-myc.RNAseq.T_1 1/1 RNA-Seq totRNA mmu Eμ-myc GSM1234734-7
GSM1234743 Eu-myc.RNAseq.T_2 1/1 RNA-Seq totRNA mmu Eμ-myc GSM1234734-7
GSM1234744 Eu-myc.RNAseq.T_3 1/1 RNA-Seq totRNA mmu Eμ-myc GSM1234734-7
GSM1234745 3T9.mycER.RNAseq.0hOHT_1 1/4 RNA-Seq totRNA mmu 3T9.mycER –
GSM1234746 3T9.mycER.RNAseq.0hOHT_2 2/4 RNA-Seq totRNA mmu 3T9.mycER –
GSM1234747 3T9.mycER.RNAseq.0hOHT_3 3/4 RNA-Seq totRNA mmu 3T9.mycER –
GSM1234748 3T9.mycER.RNAseq.0hOHT_4 4/4 RNA-Seq totRNA mmu 3T9.mycER –
GSM1234749 3T9.mycER.RNAseq.4hOHT_1 1/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234750 3T9.mycER.RNAseq.4hOHT_2 2/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234751 3T9.mycER.RNAseq.4hOHT_3 3/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234752 3T9.mycER.RNAseq.4hOHT_4 4/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234753 3T9.mycER.RNAseq.8hOHT_1 1/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234754 3T9.mycER.RNAseq.8hOHT_2 2/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234755 3T9.mycER.RNAseq.8hOHT_3 3/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234756 3T9.mycER.RNAseq.8hOHT_4 4/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234757 3T9.mycER.RNAseq.16hOHT_1 1/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234758 3T9.mycER.RNAseq.16hOHT_2 2/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234759 3T9.mycER.RNAseq.16hOHT_3 3/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234760 3T9.mycER.RNAseq.16hOHT_4 4/4 RNA-Seq totRNA mmu 3T9.mycER GSM1234745-8
GSM1234761 3T9.mycER.RNAseq.0hOHT_4sU 1/1 RNA-Seq 4sU-RNA mmu 3T9.mycER –
GSM1234762 3T9.mycER.RNAseq.4hOHT_4sU 1/1 RNA-Seq 4sU-RNA mmu 3T9.mycER GSM1234761
GSM1230377 3T9.mycER.DNAseI.0hOHT 1/2 DNAse-Seq – mmu 3T9.mycER GSM1230379
GSM1395176 3T9.mycER.DNAseI.0hOHT.B 2/2 DNAse-Seq – mmu 3T9.mycER GSM1230379
GSM1230378 3T9.mycER.DNAseI.4hOHT 1/2 DNAse-Seq – mmu 3T9.mycER GSM1230379
GSM1395177 3T9.mycER.DNAseI.4hOHT.B 2/2 DNAse-Seq – mmu 3T9.mycER GSM1230379
GSM1230379 3T9.mycER.input.DNAseI 1/1 DNAse-Seq – mmu 3T9.mycER –
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The source code is entirely written using R, an open-source language and environment for
statistical computing and graphics. In particular, several of the scripts developed for this study take
advantage of R packages developed within the Bioconductor project [4], which currently counts more
than 700 packages contributed from the scientiﬁc community, mostly dedicated to the analysis of high-
throughput biological data. In the Bioconductor spirit, most of the scripts developed for this study were
included in an R package (compEpiTools), which was recently approved as part of that project and is
available on the Bioconductor website at the following URL: http://www.bioconductor.org/packages/
release/bioc/html/compEpiTools.html. To ensure complete reproducibility, we include here the original
version of the compEpiTools package (v0.1) preceding the submission to Bioconductor, which was the one
actually used for the computational analysis of the published data. Importantly, compEpiTools (both v0.1
and following versions) is totally compliant with the Bioconductor computational infrastructures, and
therefore the results generated here are highly compatible with the other tools offered by Bioconductor.
From here on, R commands will be indicated enclosed within quotes (e.g. ‘load’), while ﬁle and
folder names will be indicated in italic (e.g. ﬁle1.txt).
3.2. Description of source code ﬁles
The source code (saboEtAl2014_sourceCode.zip) is composed by 6 ﬁles and two folders: compEpiTools_0.1.tar.gz
An R package (requires R_3.0.2) containing most of the functions and methods used for the data
analysis, including documentation and examples. The package is a preliminary version of a package
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packages/release/bioc/html/compEpiTools.html). While the package version available on the
Bioconductor web site is continuously updated, we strongly recommend using the attached
version 0.1 to exactly reproduce the analyses documented here. The compEpiTools version
available on Bioconductor can be used as reference for running examples of individual methods
that might be missing in the 0.1 compEpiTools version. The compEpiTools version 0.1 package can
be installed on Linux and MacOS systems, using the ‘install.packages’ R command. Please refer to
the R (http://www.r-project.org/) and Bioconductor (http://www.bioconductor.org/) web sites for
documentation and tutorials on the R language and common Bioconductor infrastructure (e.g. the
GRanges object) and methods. ﬁlemapping_GEO.R
Contains virtual links to the sequencing data indicated in Table 1 and processing steps used to
transform peak lists in GRanges R objects, which were saved in the R binary ﬁle peaksRef.rda in the
data folder. analysisEnvironment.R
An R script, including a number of additional compEpiTools functions and methods not contained
in compEpiTools_0.1.tar.gz. This script can be called with the ‘source’ R command when initializing
the R session. saboEtAl2014_Figures.R
An R script containing the code used to generate the main ﬁgures resulting from computational
analyses in the published paper [1]. saboEtAl2014_ExtData.R
An R script containing the code used to generate the extended ﬁgures resulting from computational
analyses in the published paper [1]. saboEtAl2014_ExtData10.R
An R script containing the code used to generate extended ﬁgure 10 in the published paper [1]. data folder
A folder containing the input and output data, formatted as R objects or text ﬁles. ﬁgures folder
A folder containing the ﬁgures resulting from the computational data analysis, which were used as
panels to assemble the main and extended ﬁgures in the published paper [1].This ﬁle is also available at the following URL: http://genomics.iit.it/supplementalData/SaboNa
ture2014. In case updated versions will be necessary they will be released there, while the original zip
ﬁle will always be available.3.3. Getting started
The ﬁle ﬁlemapping_GEO.R allows matching of the GEO samples listed in Table 1 with the
corresponding computational objects. In particular, the code shows how genomic regions such as
ChIP-Seq peaks and DNAseI-Seq hypersensitive sites were stored as GRange objects. A GRange is a
basic Bioconductor infrastructure that minimally contains the chromosome assignments as well as the
start and end nucleotide positions for a set of genomic regions. ﬁlemapping_GEO.R reports how the
ChIP-seq peaks were processed, i.e. considering the ﬁlters on the associated p-values and the pooling
of replicated experiments (see [1] methods section for a description of the actual peak calling
procedure). The ﬁnal lists of peaks were saved in the peaksRef.rda ﬁle available in the data folder.
This is a binary ﬁle containing an R object (list of GRanges) and can be loaded into R using the ‘load’ R
command.
The analysisEnvironment.R ﬁle contains a set of R commands needed for the setup of the working
environment before starting to reproduce the analyses contained in the saboEtAl2014_* ﬁles. The
‘source’ R command can be used to execute the R commands included in analysisEnvironment.R.
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steps described at the bottom of the analysisEnvironment.R ﬁle.
The saboEtAl2014_Figures.R ﬁle contains the R commands used to generate individual ﬁgures
(or panels) as indicated throughout the code. The code can be copied and pasted in the R GUI (or in the
command line shell) to obtain the resulting data or ﬁgure. Please note that some steps might depend
on the execution of previous steps reported in the same ﬁle. The results were already incorporated in
the saboEtAl2014_Figures.R ﬁle itself (in case of numbers) or included in the ﬁgures folder (in case of
ﬁgures or ﬁgure panels).
The same logic applies to saboEtAl2014_ExtData.R and saboEtAl2014_ExtData10.R for the results
reported in the extended ﬁgures.
The original FASTQ sequencing data were submitted to GEO (GSE51011 series) and are available
there as SRA ﬁles. SRA ﬁles can be transformed back to FASTQ ﬁles using the fastq-dump tool (http://
www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?view=toolkit_doc&f=fastq-dump). Finally, BAM ﬁles can be
obtained by aligning the FASTQ ﬁles the reference genome indicated in Table 1, using BWA and TopHat
aligners using default parameters for ChIP-seq and RNA-seq data, respectively.4. RNAPII stalling index analysis
The RNAPII stalling index (SI) was determined relating the RNAPII ChIP-seq reads density in the
region around the transcription start site (tss) to the density in the genebody (GB). Speciﬁcally, the SI
was obtained as a ratio of the number of reads counted on RNAPII alignment ﬁles in the interval
[tss300 bp, tssþ300] (TSS) and [tssþ300, transcription end siteþ3000] (GB): SI¼TSS/GB [5].
In literature, this quantity was referred alternatively as travelling ratio (TR¼GB/TSS) [6]; yet, some
studies refer as travelling ratio the ratio TSS/GB [7,8]. The stalling index was computed considering all
transcripts whose length was above 600 bp having an RNAPII ChIP-seq peak on their TSS. Since the
stalling index reﬂects the balance between two different effects (the amount of RNAPII loaded on the
TSS of a gene, and the amount of RNAPII travelling on the genebody), the code in the R source ﬁle
saboEtAl2014_ExtData10.R clariﬁes this point by separately plotting the TSS and GB read distributions
along with the SI.Acknowledgements
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